Kevin Tang
CEO at Aurinia Pharmaceuticals Inc. (AUPH); Director at Aurinia Pharmaceuticals Inc. (AUPH); 10% Owner at Boundless Bio, Inc. (BOLD); 10% Owner at Fulcrum Therapeutics, Inc. (FULC)
Purchase track record
Market-like. Based on 5 purchases with a full 90 days of price history.
50
Avg. 90-day return+4.9%
vs. S&P 500+0.1%
Beat the market60%
Paper profit on buys+$3.5M
Total bought / sold$27.3M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 21SEC | BOLDBoundless Bio, Inc. | Buy | 2652,854,337 held (+0%) | $2.44 | $647 | +3.7% |
| Jul 21SEC | BOLDBoundless Bio, Inc. | Buy | 1,6232,855,960 held (+0%) | $2.44 | $4K | +3.7% |
| Jul 21SEC | BOLDBoundless Bio, Inc. | Buy | 2,9752,858,935 held (+0%) | $2.44 | $7K | +3.7% |
| Jul 20SEC | FULCFulcrum Therapeutics, Inc. | Buy | 116,6717,030,000 held (+2%) | $3.56 | $415K | +5.9% |
| Jul 20SEC | FULCFulcrum Therapeutics, Inc. | Buy | 50,9457,080,945 held (+1%) | $3.52 | $179K | +7.1% |
| Jul 16SEC | BOLDBoundless Bio, Inc. | Buy | 43,8782,833,981 held (+2%) | $2.43 | $107K | +4.1% |
| Jul 16SEC | BOLDBoundless Bio, Inc. | Buy | 1,6002,835,581 held (+0%) | $2.44 | $4K | +3.7% |
| Jul 16SEC | BOLDBoundless Bio, Inc. | Buy | 18,4912,854,072 held (+1%) | $2.44 | $45K | +3.7% |
| Jul 13SEC | BOLDBoundless Bio, Inc. | Buy | 72,698,525 held (+0%) | $2.48 | $17 | +2.0% |
| Jul 13SEC | BOLDBoundless Bio, Inc. | Buy | 43,3672,741,892 held (+2%) | $2.43 | $105K | +4.1% |
| Jul 13SEC | BOLDBoundless Bio, Inc. | Buy | 48,2112,790,103 held (+2%) | $2.42 | $117K | +4.5% |
| Jul 8SEC | BOLDBoundless Bio, Inc. | Buy | 27,0622,668,370 held (+1%) | $2.49 | $67K | +1.6% |
| Jul 8SEC | BOLDBoundless Bio, Inc. | Buy | 15,8102,684,180 held (+1%) | $2.48 | $39K | +2.0% |
| Jul 8SEC | BOLDBoundless Bio, Inc. | Buy | 14,3382,698,518 held (+1%) | $2.46 | $35K | +2.8% |
| Jul 2SEC | BOLDBoundless Bio, Inc. | Buy | 25,9302,559,775 held (+1%) | $2.54 | $66K | -0.4% |
| Jul 2SEC | BOLDBoundless Bio, Inc. | Buy | 1002,559,875 held (+0%) | $2.50 | $250 | +1.2% |
| Jul 2SEC | BOLDBoundless Bio, Inc. | Buy | 71,6122,631,487 held (+3%) | $2.49 | $178K | +1.6% |
| Jul 2SEC | BOLDBoundless Bio, Inc. | Buy | 9,8212,641,308 held (+0%) | $2.49 | $24K | +1.6% |
| Jun 29SEC | BOLDBoundless Bio, Inc. | Buy | 145,8802,393,392 held (+6%) | $2.48 | $362K | +2.0% |
| Jun 29SEC | BOLDBoundless Bio, Inc. | Buy | 5102,393,902 held (+0%) | $2.56 | $1K | -1.2% |
| Jun 29SEC | BOLDBoundless Bio, Inc. | Buy | 75,0472,468,949 held (+3%) | $2.55 | $191K | -0.8% |
| Jun 29SEC | BOLDBoundless Bio, Inc. | Buy | 1342,469,083 held (+0%) | $2.54 | $340 | -0.4% |
| Jun 29SEC | BOLDBoundless Bio, Inc. | Buy | 63,9852,533,068 held (+3%) | $2.47 | $158K | +2.4% |
| Jun 29SEC | BOLDBoundless Bio, Inc. | Buy | 7772,533,845 held (+0%) | $2.48 | $2K | +2.0% |
| Jun 2SEC | AUPHAurinia Pharmaceuticals Inc. | Buy | 2,29912,231,799 held (+0%) | $15.35 | $35K | +8.5% |
| Jun 2SEC | AUPHAurinia Pharmaceuticals Inc. | Buy | 262,68212,494,481 held (+2%) | $15.31 | $4.0M | +8.8% |
| Jun 2SEC | AUPHAurinia Pharmaceuticals Inc. | Buy | 343,52112,838,002 held (+3%) | $15.28 | $5.2M | +9.0% |
| Jun 2SEC | AUPHAurinia Pharmaceuticals Inc. | Buy | 9912,838,101 held (+0%) | $15.34 | $2K | +8.5% |
| Jun 2SEC | AUPHAurinia Pharmaceuticals Inc. | Buy | 206,00513,044,106 held (+2%) | $15.28 | $3.1M | +9.0% |
| Mar 3SEC | AUPHAurinia Pharmaceuticals Inc. | Buy | 300,00011,629,500 held (+3%) | $13.90 | $4.2M | +19.8% |
| Mar 3SEC | AUPHAurinia Pharmaceuticals Inc. | Buy | 214,83911,844,339 held (+2%) | $14.12 | $3.0M | +17.9% |
| Mar 3SEC | AUPHAurinia Pharmaceuticals Inc. | Buy | 1,60011,845,939 held (+0%) | $14.38 | $23K | +15.8% |
| Mar 3SEC | AUPHAurinia Pharmaceuticals Inc. | Buy | 83,56111,929,500 held (+1%) | $14.33 | $1.2M | +16.2% |
| Mar 3SEC | AUPHAurinia Pharmaceuticals Inc. | Buy | 115,79212,045,292 held (+1%) | $14.21 | $1.6M | +17.2% |
| Mar 3SEC | AUPHAurinia Pharmaceuticals Inc. | Buy | 184,20812,229,500 held (+2%) | $14.22 | $2.6M | +17.1% |
- Buy
10% Owner Kevin Tang bought $415K of FULC at $3.56 — first open-market purchase in our records.
- Buy
10% Owner Kevin Tang bought $362K of BOLD at $2.48 — first open-market purchase in our records.
- Buy
CEO Kevin Tang bought $5.2M of AUPH at $15.28 — largest purchase by this insider in our records.
- Buy
Director Kevin Tang bought $4.2M of AUPH at $13.90 — first open-market purchase in our records.